| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00103-013-1854-7 |
| P698 | PubMed publication ID | 24337128 |
| P2093 | author name string | M Entezami | |
| M Stumm | |||
| P2860 | cites work | Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 |
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing | Q28742844 | ||
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
| Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation | Q33680368 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. | Q34249522 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Pregnancy loss rates after midtrimester amniocentesis | Q34578193 | ||
| Operator experience reduces the risk of second trimester amniocentesis-related adverse outcomes | Q44403124 | ||
| One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies | Q45078884 | ||
| Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors | Q46446186 | ||
| Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. | Q46892061 | ||
| Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithms | Q47785370 | ||
| First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. | Q50552934 | ||
| Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe. | Q51142138 | ||
| Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. | Q51321305 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age. | Q51644426 | ||
| 'Normal' nuchal translucency: a justification to refrain from detailed scan? Analysis of 6858 cases with special reference to ethical aspects. | Q52888686 | ||
| Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. | Q52933856 | ||
| Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. | Q52941261 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Performing a Fetal Anatomy Scan at the Time of First-Trimester Screening | Q57285079 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 1662-1669 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Bundesgesundheitsblatt | Q1006114 |
| P1476 | title | [Prenatal diagnostics: current medical aspects]. | |
| P478 | volume | 56 |
Search more.